| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 14.7% | n/a |
| ROCE | 5.7% |
| Latest | F'cast | |
|---|---|---|
| P/E | 22.9 | n/a |
| PEG | 1.0 | n/a |
| Pr/Revenue | 2.0 | n/a |
| Pr/Book | 0.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 46.4% | n/a |
| PBT | n/a | n/a |
| EPS | 23.8% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 418.50 | (245.10) | (144.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 523.50 | (70.70) | (42.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 648.90 | 30.50 | 13.80p | 2.7 | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 405.30 | (212.10) | 6.30p | 15.0 | n/a | -54% | n/a | 0.0% |
| 31-Dec-25 | 593.30 | 87.20 | 7.80p | 15.5 | 0.6 | +24% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Holding(s) in Company | 07-Sep-2026 | 15:02 | EQS Group |
| Director/PDMR Shareholding | 03-Sep-2026 | 16:51 | EQS Group |
| Shares Admitted to Trading and Total Voting Rights | 01-Sep-2026 | 15:00 | EQS Group |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 02-Sep-26 | Buy | Jaime Gilinski Bacal | 172.00p | 500,000 | £860,000.01 |
| Currency | UK Pounds |
| Share Price | 181.60p |
| Change Today | 2.40p |
| % Change | 1.34 % |
| 52 Week High | 183.40 |
| 52 Week Low | 100.00 |
| Volume | 253,633 |
| Shares Issued | 673.63m |
| Market Cap | £1,223.31m |
| RiskGrade | 336 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:34 | 197 @ 181.50p |
| 10:27 | 1,456 @ 181.53p |
| 10:27 | 1,600 @ 181.40p |
| 10:22 | 3 @ 181.40p |
| 10:22 | 2,349 @ 181.50p |
| CEO | Daniel Frumkin |
| Chair | Robert Sharpe |
| CFO | Marc Page |
You are here: research